Aileron Therapeutics Announces Acquisition of Lung Therapeutics
/PRNewswire/ -- Aileron Therapeutics, Inc. ("Aileron") (NASDAQ: ALRN) today announced it has acquired Lung Therapeutics, Inc. ("Lung Tx"), a privately held...
Stay updated with breaking news from Bios Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Aileron Therapeutics, Inc. ("Aileron") (NASDAQ: ALRN) today announced it has acquired Lung Therapeutics, Inc. ("Lung Tx"), a privately held...
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
By Denny Jacob Clinical-stage biopharmaceutical company Azitra said Tuesday it appointed Travis Whitfill as chief operating officer. Whitfill co-founded...
/PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision...
Opus Genetics, a Durham-based company developing drugs to treat retinal diseases has raised an additional $4.5 million from investors. Here's how the CEO plans to invest the money.